Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1993 Apr;61(4):1268-71.
doi: 10.1128/iai.61.4.1268-1271.1993.

Experimental hematogenous candidiasis caused by Candida krusei and Candida albicans: species differences in pathogenicity

Affiliations
Comparative Study

Experimental hematogenous candidiasis caused by Candida krusei and Candida albicans: species differences in pathogenicity

E Anaissie et al. Infect Immun. 1993 Apr.

Abstract

Hematogenous infections caused by Candida krusei have been noted with increasing frequency, particularly in cancer patients receiving prophylaxis with antifungal triazoles. Progress in understanding the pathogenesis of this emerging infection has been limited by the lack of an animal model. We developed a CF1 mouse intravenous inoculation model of candidiasis to evaluate the pathogenicity of C. krusei in normal and immunosuppressed mice and to compare it with that of Candida albicans. Several inocula (10(6) to 10(8) CFU per animal) of two clinical strains of C. krusei and three American Type Culture Collection strains of C. albicans were tested. Groups of 20 mice each were injected with a single intravenous dose of one inoculum. Animals randomized to receive C. krusei were immunosuppressed by intraperitoneal injection of cyclophosphamide or the combination of cyclophosphamide plus cortisone acetate or they did not receive immunosuppressive agents (normal mice). One hundred percent mortality was observed in normal mice injected with 10(6) CFU of C. albicans per mouse compared with no mortality in normal mice that received 10(8) CFU of C. krusei per mouse (P < 0.01). Resistance to C. krusei infection was markedly lowered by immunosuppression, particularly by the combination of cyclophosphamide plus cortisone acetate, with a significantly shorter survival and a higher organ fungal burden in immunosuppressed than in normal animals (P < 0.01). Tissue infection was documented by culture and histopathologic findings in all examined organs.

PubMed Disclaimer

References

    1. J Clin Microbiol. 1986 Oct;24(4):581-4 - PubMed
    1. Antimicrob Agents Chemother. 1989 Sep;33(9):1443-6 - PubMed
    1. Chemotherapy. 1990;36(6):396-402 - PubMed
    1. J Reticuloendothel Soc. 1970 Nov;8(5):421-33 - PubMed
    1. Clin Infect Dis. 1992 Mar;14 Suppl 1:S43-53 - PubMed

Publication types